|
 |
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
American Journal of Public Health, 10.2105/AJPH.2004.051110
Commentaries |
1 University of North Carolina at Chapel Hill
2 Univrsity of North Carolina at Chapel Hill
3 University of Kansas
* To whom correspondence should be addressed. E-mail: don_bailey{at}unc.edu.
 |
Abstract |
|---|
A fundamental tenet of newborn screening is proven benefit to the infant. Many conditions causing developmental disabilities do not currently meet this standard, usually construed as medical benefit that significantly improves child health. We argue for expanding concepts of presumptive benefit. Newborn screening provides access to early intervention programs shown to positively influence children's development and support families. Consumers want information about their children's health and their own reproductive risk, and they have a broader view than policymakers of what constitutes a treatable disorder. Newborn screening provides other societal benefits that, in the absence of data showing harm and with appropriate attention to ethical and legal issues, warrant consideration of an expansion of targets of newborn screening.
Key Words: Disability, Health Policy, Screening
This article has been cited by other articles:
|
|
 |
|
  D. B. Bailey Jr, M. Raspa, E. Bishop, and D. Holiday No Change in the Age of Diagnosis for Fragile X Syndrome: Findings From a National Parent Survey Pediatrics, August 1, 2009; 124(2): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Bailey Jr, F. D. Armstrong, A. R. Kemper, D. Skinner, and S. F. Warren Supporting Family Adaptation to Presymptomatic and "Untreatable" Conditions in an Era of Expanded Newborn Screening J. Pediatr. Psychol., July 1, 2009; 34(6): 648 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Fernandez-Carvajal, P. Walichiewicz, X. Xiaosen, R. Pan, P. J. Hagerman, and F. Tassone Screening for Expanded Alleles of the FMR1 Gene in Blood Spots from Newborn Males in a Spanish Population J. Mol. Diagn., July 1, 2009; 11(4): 324 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Bailey Jr, D. Skinner, A. M. Davis, I. Whitmarsh, and C. Powell Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues Pediatrics, March 1, 2008; 121(3): e693 - e704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tassone, R. Pan, K. Amiri, A. K. Taylor, and P. J. Hagerman A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk Populations J. Mol. Diagn., January 1, 2008; 10(1): 43 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Bailey Jr, L. Nelson, K. Hebbeler, and D. Spiker Modeling the Impact of Formal and Informal Supports for Young Children With Disabilities and Their Families Pediatrics, October 1, 2007; 120(4): e992 - e1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Tarini The Current Revolution in Newborn Screening: New Technology, Old Controversies Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 767 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Howell We Need Expanded Newborn Screening Pediatrics, May 1, 2006; 117(5): 1800 - 1805. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |